000 01472 a2200445 4500
005 20250515110611.0
264 0 _c20080926
008 200809s 0 0 eng d
022 _a1078-0998
024 7 _a10.1002/ibd.20405
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDin, Shahida
245 0 0 _aUse of methotrexate in refractory Crohn's disease: the Edinburgh experience.
_h[electronic resource]
260 _bInflammatory bowel diseases
_cJun 2008
300 _a756-62 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aAntibodies, Monoclonal
_xadministration & dosage
650 0 4 _aAzathioprine
_xadministration & dosage
650 0 4 _aCrohn Disease
_xdrug therapy
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aImmunosuppressive Agents
_xadministration & dosage
650 0 4 _aInfliximab
650 0 4 _aInjections, Intramuscular
650 0 4 _aMale
650 0 4 _aMethotrexate
_xadministration & dosage
650 0 4 _aPrednisolone
_xtherapeutic use
650 0 4 _aRemission Induction
650 0 4 _aRetrospective Studies
700 1 _aDahele, Anna
700 1 _aFennel, Janice
700 1 _aAitken, Sue
700 1 _aShand, Alan G
700 1 _aArnott, Ian D R
700 1 _aSatsangi, Jack
773 0 _tInflammatory bowel diseases
_gvol. 14
_gno. 6
_gp. 756-62
856 4 0 _uhttps://doi.org/10.1002/ibd.20405
_zAvailable from publisher's website
999 _c17779867
_d17779867